Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Great Potential for Faster Diagnoses with New Method

Published: Monday, October 21, 2013
Last Updated: Monday, October 21, 2013
Bookmark and Share
The more accurately we can diagnose a disease, the greater the chance that the patient will survive.

That is why many researchers are working to improve the quality of the diagnostic process. Researchers at the Nano-Science Center, University of Copenhagen have discovered a method that will make the process faster, cheaper and more accurate. This is possible, because they are combining advanced tools used in physics for research in biology at nanoscale, two scientific disciplines usually very distant from each other.

Many diseases can be diagnosed using so-called biomarkers. There are substances, for example, that can be measured in a blood sample, which shows that the patient is suffering from the disease in question. These biomarkers are often proteins that are found in very small quantities in the blood, making it difficult to detect them. By measuring them, the diagnosing is more precise and many diseases can be detected very early, before the patient develops severe symptoms.

- We have developed a method in which we optimise the analysis of the proteins. A central point of this method is the use of nanowires to hold the proteins while we analyse them. It is unique, explains Katrine R. Rostgaard, a PhD student at the Nano-Science Center, Department of Chemistry, University of Copenhagen.

Researchers normally use small plates to hold the proteins when they need to be analysed, but by using nanowires, which are cylindrical structures having a diameter of about 1/1000th of a human hair, they add a third dimension to the sample. The nanowires stand up like a little forest, creating a much greater surface area to hold the proteins because they can sit on all sides of the nanowire.

- With greater area, we can hold more proteins at once. This makes it possible to measure for multiple biomarkers simultaneously and it increases the signal, thereby providing a better quality of diagnosis, says Katrine R. Rostgaard about the method, which has just been published in the journal Nanoscale.

Profitable method for diagnosing
The research is done at the nanoscale on small size samples. The forests of nanowires are used to capture the proteins they want to study directly. When examining the proteins, you can reuse the nanowires by performing a multiple tests on the same protein. This simplifies the workflow in the laboratory tremendously in comparison to the conventional method, where researchers have to start over with a new plate to hold the proteins every time they perform a new analysis. In this way, the method helps to make the diagnostic process more environmentally friendly and economically viable for use in, for example, industry.

- We know that several major biotech companies will be interested in our new method and find potential applications, though it requires improvements before it is ready for use in the industry, explains Karen Martinez, research group leader of the Nanobio group at the Nano-Science Center, Department of Chemistry, University of Copenhagen.

The work is part of two larger projects, ANaCell and UNIK Center for Synthetic Biology, which is financed by The Danish Council for Strategic Research and the Ministry of Science, Technology and Innovation.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!